Clinical Trials Directory

Trials / Unknown

UnknownNCT01191710

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

Is the Clinical Outcome Affected by the Incidence of Progesterone Elevation on the Day of hCG Triggering When Agonist Protocol is Compared to Antagonist Protocol for IVF

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
Female
Age
21 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The aim is to explore whether the incidence of progesterone rise in the late follicular phase differs between GnRH-agonist and GnRH-antagonist protocols for IVF and whether this has an impact on the probability of pregnancy achievement.

Detailed description

In view of the current debate concerning possible differences in efficacy between the two GnRH analogues, the current study aimed to explore whether progesterone control in the late follicular phase differs when GnRH-agonist is used as compared to GnRH-antagonist and if so to what extend does the progesterone rise have an impact on the probability of achieving a pregnancy.

Conditions

Interventions

TypeNameDescription
OTHERIn vitro fertilizationIn vitro fertilization procedure with gonadotropin induced follicular ovarian stimulation

Timeline

Start date
2007-01-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-08-31
Last updated
2010-09-15

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01191710. Inclusion in this directory is not an endorsement.